Literature DB >> 27797809

Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia.

Sarat C Vatsavayai1, Soo Jin Yoon2, Raquel C Gardner1, Tania F Gendron3, Jose Norberto S Vargas1, Andrew Trujillo1, Mochtar Pribadi4, Joanna J Phillips5, Stephanie E Gaus1, John D Hixson6, Paul A Garcia6, Gil D Rabinovici1, Giovanni Coppola4, Daniel H Geschwind4, Leonard Petrucelli3, Bruce L Miller1, William W Seeley7,8.   

Abstract

SEE SCABER AND TALBOT DOI101093/AWW264 FOR A SCIENTIFIC COMMENTARY ON THIS ARTICLE: A GGGGCC repeat expansion in C9orf72 leads to frontotemporal dementia and/or amyotrophic lateral sclerosis. Diverse pathological features have been identified, and their disease relevance remains much debated. Here, we describe two illuminating patients with frontotemporal dementia due to the C9orf72 repeat expansion. Case 1 was a 65-year-old female with behavioural variant frontotemporal dementia accompanied by focal degeneration in subgenual anterior cingulate cortex, amygdala, and medial pulvinar thalamus. At autopsy, widespread RNA foci and dipeptide repeat protein inclusions were observed, but TDP-43 pathology was nearly absent, even in degenerating brain regions. Case 2 was a 74-year-old female with atypical frontotemporal dementia-motor neuron disease who underwent temporal lobe resection for epilepsy 5 years prior to her first frontotemporal dementia symptoms. Archival surgical resection tissue contained RNA foci, dipeptide repeat protein inclusions, and loss of nuclear TDP-43 but no TDP-43 inclusions despite florid TDP-43 inclusions at autopsy 8 years after first symptoms. These findings suggest that C9orf72-specific phenomena may impact brain structure and function and emerge before first symptoms and TDP-43 aggregation.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  TDP-43; frontotemporal dementia; protein aggregation

Mesh:

Substances:

Year:  2016        PMID: 27797809      PMCID: PMC5790143          DOI: 10.1093/brain/aww250

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  41 in total

1.  Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations.

Authors:  Ian R Mackenzie; Thomas Arzberger; Elisabeth Kremmer; Dirk Troost; Stefan Lorenzl; Kohji Mori; Shih-Ming Weng; Christian Haass; Hans A Kretzschmar; Dieter Edbauer; Manuela Neumann
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

2.  Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells.

Authors:  Ilmin Kwon; Siheng Xiang; Masato Kato; Leeju Wu; Pano Theodoropoulos; Tao Wang; Jiwoong Kim; Jonghyun Yun; Yang Xie; Steven L McKnight
Journal:  Science       Date:  2014-07-31       Impact factor: 47.728

3.  The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.

Authors:  Kohji Mori; Shih-Ming Weng; Thomas Arzberger; Stephanie May; Kristin Rentzsch; Elisabeth Kremmer; Bettina Schmid; Hans A Kretzschmar; Marc Cruts; Christine Van Broeckhoven; Christian Haass; Dieter Edbauer
Journal:  Science       Date:  2013-02-07       Impact factor: 47.728

4.  Thalamic dementia: report of a case with unusual lesion location.

Authors:  G Abbruzzese; L Arata; G Bino; D Dall'Agata; A Leonardi
Journal:  Ital J Neurol Sci       Date:  1986-02

5.  RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.

Authors:  Christopher J Donnelly; Ping-Wu Zhang; Jacqueline T Pham; Aaron R Haeusler; Aaron R Heusler; Nipun A Mistry; Svetlana Vidensky; Elizabeth L Daley; Erin M Poth; Benjamin Hoover; Daniel M Fines; Nicholas Maragakis; Pentti J Tienari; Leonard Petrucelli; Bryan J Traynor; Jiou Wang; Frank Rigo; C Frank Bennett; Seth Blackshaw; Rita Sattler; Jeffrey D Rothstein
Journal:  Neuron       Date:  2013-10-16       Impact factor: 17.173

6.  Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72.

Authors:  Bradley F Boeve; Kevin B Boylan; Neill R Graff-Radford; Mariely DeJesus-Hernandez; David S Knopman; Otto Pedraza; Prashanthi Vemuri; David Jones; Val Lowe; Melissa E Murray; Dennis W Dickson; Keith A Josephs; Beth K Rush; Mary M Machulda; Julie A Fields; Tanis J Ferman; Matthew Baker; Nicola J Rutherford; Jennifer Adamson; Zbigniew K Wszolek; Anahita Adeli; Rodolfo Savica; Brendon Boot; Karen M Kuntz; Ralitza Gavrilova; Andrew Reeves; Jennifer Whitwell; Kejal Kantarci; Clifford R Jack; Joseph E Parisi; John A Lucas; Ronald C Petersen; Rosa Rademakers
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

7.  Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing.

Authors:  Martin H Schludi; Stephanie May; Friedrich A Grässer; Kristin Rentzsch; Elisabeth Kremmer; Clemens Küpper; Thomas Klopstock; Thomas Arzberger; Dieter Edbauer
Journal:  Acta Neuropathol       Date:  2015-06-18       Impact factor: 17.088

8.  Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS.

Authors:  Tania F Gendron; Kevin F Bieniek; Yong-Jie Zhang; Karen Jansen-West; Peter E A Ash; Thomas Caulfield; Lillian Daughrity; Judith H Dunmore; Monica Castanedes-Casey; Jeannie Chew; Danielle M Cosio; Marka van Blitterswijk; Wing C Lee; Rosa Rademakers; Kevin B Boylan; Dennis W Dickson; Leonard Petrucelli
Journal:  Acta Neuropathol       Date:  2013-10-16       Impact factor: 17.088

9.  Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic.

Authors:  Youn-Bok Lee; Han-Jou Chen; João N Peres; Jorge Gomez-Deza; Jan Attig; Maja Stalekar; Claire Troakes; Agnes L Nishimura; Emma L Scotter; Caroline Vance; Yoshitsugu Adachi; Valentina Sardone; Jack W Miller; Bradley N Smith; Jean-Marc Gallo; Jernej Ule; Frank Hirth; Boris Rogelj; Corinne Houart; Christopher E Shaw
Journal:  Cell Rep       Date:  2013-11-27       Impact factor: 9.423

10.  C9orf72 nucleotide repeat structures initiate molecular cascades of disease.

Authors:  Aaron R Haeusler; Christopher J Donnelly; Goran Periz; Eric A J Simko; Patrick G Shaw; Min-Sik Kim; Nicholas J Maragakis; Juan C Troncoso; Akhilesh Pandey; Rita Sattler; Jeffrey D Rothstein; Jiou Wang
Journal:  Nature       Date:  2014-03-05       Impact factor: 49.962

View more
  61 in total

Review 1.  Phenotypic Suppression of ALS/FTD-Associated Neurodegeneration Highlights Mechanisms of Dysfunction.

Authors:  Mathieu Bartoletti; Daryl A Bosco; Sandrine Da Cruz; Clotilde Lagier-Tourenne; Nicole Liachko; Sebastian Markmiller; Kristin M Webster; Kristi A Wharton
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

Review 2.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

3.  Cryptic exon incorporation occurs in Alzheimer's brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43.

Authors:  Mingkuan Sun; William Bell; Katherine D LaClair; Jonathan P Ling; Heather Han; Yusuke Kageyama; Olga Pletnikova; Juan C Troncoso; Philip C Wong; Liam L Chen
Journal:  Acta Neuropathol       Date:  2017-03-22       Impact factor: 17.088

4.  Dipeptide repeat protein and TDP-43 pathology along the hypothalamic-pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases.

Authors:  Lieselot Dedeene; Evelien Van Schoor; Simona Ospitalieri; Alicja Ronisz; Jochen H Weishaupt; Markus Otto; Albert C Ludolph; Angelika Scheuerle; Rik Vandenberghe; Philip Van Damme; Koen Poesen; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2020-08-30       Impact factor: 17.088

Review 5.  RNA-mediated toxicity in C9orf72 ALS and FTD.

Authors:  Zachary T McEachin; Janani Parameswaran; Nisha Raj; Gary J Bassell; Jie Jiang
Journal:  Neurobiol Dis       Date:  2020-08-21       Impact factor: 5.996

6.  Fluid Biomarkers of Frontotemporal Lobar Degeneration.

Authors:  Emma L van der Ende; John C van Swieten
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Treatment of Seizures in Older Patients with Dementia.

Authors:  Benjamin Cretin
Journal:  Drugs Aging       Date:  2020-12-14       Impact factor: 3.923

8.  C9orf72 Poly(PR) Dipeptide Repeats Disturb Biomolecular Phase Separation and Disrupt Nucleolar Function.

Authors:  Michael R White; Diana M Mitrea; Peipei Zhang; Christopher B Stanley; Devon E Cassidy; Amanda Nourse; Aaron H Phillips; Michele Tolbert; J Paul Taylor; Richard W Kriwacki
Journal:  Mol Cell       Date:  2019-04-10       Impact factor: 17.970

9.  Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis.

Authors:  Tania F Gendron; Jeannie Chew; Jeannette N Stankowski; Lindsey R Hayes; Yong-Jie Zhang; Mercedes Prudencio; Yari Carlomagno; Lillian M Daughrity; Karen Jansen-West; Emilie A Perkerson; Aliesha O'Raw; Casey Cook; Luc Pregent; Veronique Belzil; Marka van Blitterswijk; Lilia J Tabassian; Chris W Lee; Mei Yue; Jimei Tong; Yuping Song; Monica Castanedes-Casey; Linda Rousseau; Virginia Phillips; Dennis W Dickson; Rosa Rademakers; John D Fryer; Beth K Rush; Otto Pedraza; Ana M Caputo; Pamela Desaro; Carla Palmucci; Amelia Robertson; Michael G Heckman; Nancy N Diehl; Edythe Wiggs; Michael Tierney; Laura Braun; Jennifer Farren; David Lacomis; Shafeeq Ladha; Christina N Fournier; Leo F McCluskey; Lauren B Elman; Jon B Toledo; Jennifer D McBride; Cinzia Tiloca; Claudia Morelli; Barbara Poletti; Federica Solca; Alessandro Prelle; Joanne Wuu; Jennifer Jockel-Balsarotti; Frank Rigo; Christine Ambrose; Abhishek Datta; Weixing Yang; Denitza Raitcheva; Giovanna Antognetti; Alexander McCampbell; John C Van Swieten; Bruce L Miller; Adam L Boxer; Robert H Brown; Robert Bowser; Timothy M Miller; John Q Trojanowski; Murray Grossman; James D Berry; William T Hu; Antonia Ratti; Bryan J Traynor; Matthew D Disney; Michael Benatar; Vincenzo Silani; Jonathan D Glass; Mary Kay Floeter; Jeffrey D Rothstein; Kevin B Boylan; Leonard Petrucelli
Journal:  Sci Transl Med       Date:  2017-03-29       Impact factor: 17.956

Review 10.  RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.

Authors:  Jeffrey W Hofmann; William W Seeley; Eric J Huang
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.